St Vincents Private Hospitals

Biography

In October 2020 Dr Long was ranked as the world's 4th, and Australia's 1st melanoma expert in all fields and disciplines.

Professor Georgina Long AO, BSc PhD MBBS FRACP FAHMS, is Co-Medical Director of Melanoma Institute Australia (MIA), and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney. She leads an extensive clinical trials team and laboratory at MIA, with a focus on targeted therapies and immuno-oncology in melanoma. She is principal investigator on phase I, II and III clinical trials in adjuvant and metastatic melanoma, including trials in patients with active brain metastases. She is the chief investigator on NHMRC funded research into the molecular biology of melanoma, with a particular interest in clinical and tissue biomarker correlates of systemic therapy sensitivity and resistance.
 
In recognition of her ground-breaking research and work, Professor Long was recognized with the Australian Academy of Health and Medical Sciences Outstanding Female Research Medal 2021 and was appointed as an Officer of the Order of Australia (2020) and has received several awards, including the Research Australia, GSK Research Excellence Award (2018) and prestigious Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research (2016). She has a number of CINSW Premiers Awards, including; the Outstanding Cancer Researcher (2018), the Excellence in Translational Cancer Research Award (2017), the Wildfire Award for the most highly-cited, original, peer-reviewed article published (2011, 2014, 2016 & 2017), and in 2013 she was named the Outstanding Cancer Research Fellow.  She is also Clarivate highly-cited Researcher for 2017-2021.  Her H index is 107 and in September 2021 she was ranked the world’s 2nd, and Australia’s 1^st melanoma expert in all fields and discipline (http://expertscape.com/ex/melanoma)
 
Professor Long is the author of over 360 peer-reviewed publications in clinical and translational research in melanoma, including the New England Journal of Medicine, Lancet, Lancet Oncology, Science, Nature, Lancet Oncology, Journal of Clinical Oncology and Cancer Discovery.  Professor Long has presented her work at international conferences and meetings on more than 200 occasions. She is Past President for the prestigious international Society for Melanoma Research (2018-2020), is a member and Chair of the ASCO (2015-2017) and ESMO (2017-2020) Scientific Committee for Melanoma/Skin cancer, is medical oncology lead for the Australian Melanoma Management Guidelines Committee, is  on the editorial boards  of several  high-impact  journals,  and is a member of the Melanoma Expert Panel for AJCC Cancer Staging System 8th edition.
 
Professor Long was awarded the University Medal in Organic Chemistry. She subsequently completed her PhD in Chemistry in the field of anti-cancer agents and their binding to DNA. She then moved to the USA to take up a Fulbright Postdoctoral Fellowship at Scripps Research Institute, exploring nanotechnology in cancer treatment, before returning to Australia to complete her MBBS (Hons). Professor Long became a Fellow of the Australasian College of Physicians in January 2008, specialising in medical oncology.